Modelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland


Autoria(s): Scotland, G; McKeigue, S; Philip, P; Leese, GP; Olson, J A; Looker, H C; Colhoun, H M; Javanbakht, M
Contribuinte(s)

University of Aberdeen, Medicine, Medical Sciences & Nutrition, HERU

Data(s)

05/08/2016

05/08/2016

11/05/2016

Resumo

Funding sources: The study was funded by a research grant from the Chief Scientist’s Office of the Scottish Government Health and Social Care Directorates (CZH/4/971). The funder played no role in study design, data collection, data analysis, manuscript preparation and/or publication decisions. The views expressed herein are those of the authors and do not necessarily reflect those of the funder.

Peer reviewed

Postprint

Identificador

Scotland , G , McKeigue , S , Philip , P , Leese , G P , Olson , J A , Looker , H C , Colhoun , H M & Javanbakht , M 2016 , ' Modelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland ' Diabetic Medicine . , 10.1111/dme.13129

0742-3071

PURE: 64964293

PURE UUID: beb46b37-4887-4dff-a140-ebb512ac934c

http://hdl.handle.net/2164/6995

http://dx.doi.org/10.1111/dme.13129

Idioma(s)

eng

Relação

Diabetic Medicine

Direitos

"This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving."

Palavras-Chave #R Medicine #Chief Scientist Office (CSO) #CZH/4/971 #R
Tipo

Journal article